Literature DB >> 26885241

Effects of dexmedetomidine versus propofol on SPO2 in children with tetralogy of fallot during anesthesia.

Hongbin Gu1, Jie Bai1, Jinfen Liu2.   

Abstract

OBJECTIVE: To determine effects of DEX versus propofol on saturation of pulse oximetry (SPO2) in children with Tetralogy of Fallot (TOF) during anesthesia.
METHODS: 54 children with TOF who planned to receive corrected operation were randomly assigned to two groups: group DEX and group Propofol. Indicators were compared at T0 (immediate induction of anesthesia), T1 (tracheal catheterization), T2 (skin incision), T3 (sternal exposure) and T4 (aortic catheterization).
RESULTS: In group DEX, the hear rate (HR) and partial pressure difference between alveolar air and arteries [P(A-a)O2] at T1 were lower than those at T0, while systolic blood pressure (SBP), diastolic blood pressure (DBP), mean blood pressure (MBP) and SPO2 at T1 were higher than those at T0, with statistically significant differences (P<0.05, respectively). In the group Propofol, SBP, DBP, MBP and SPO2 at T1 were lower than those at T0, while P(A-a)O2 at T1 was higher than that at T0, with statistically significant differences (P<0.05, respectively). There were statistically significant differences in all indicators at T1 between two groups (P<0.05, respectively). The group DEX had lower HR and P(A-a)O2, and higher SBP, DBP, MBP and SPO2 than group Propofol. There were no statistically significant differences in all indicators (except for lower HR) at other points between two groups.
CONCLUSION: During induction of anesthesia, DEX was better than propofol to improve alveolar oxygenation, reduce myocardial oxygen consumption, increase arterial oxygen content and induce stable induction in patients with TOF, though they were comparable during maintenance of anesthesia.

Entities:  

Keywords:  Tetralogy of fallot; anesthesia; dexmedetomidine; propofol

Year:  2015        PMID: 26885241      PMCID: PMC4730027     

Source DB:  PubMed          Journal:  Int J Clin Exp Med        ISSN: 1940-5901


  12 in total

1.  Dexmedetomidine: another arrow for the clinician's quiver.

Authors:  Thomas Ebert; Mervyn Maze
Journal:  Anesthesiology       Date:  2004-09       Impact factor: 7.892

2.  Prolonged infusion of dexmedetomidine for sedation following tracheal resection.

Authors:  Gregory B Hammer; Bridget M Philip; Alan R Schroeder; Frederick S Rosen; Peter J Koltai
Journal:  Paediatr Anaesth       Date:  2005-07       Impact factor: 2.556

Review 3.  Use of dexmedetomidine as a sedative and analgesic agent in critically ill adult patients: a meta-analysis.

Authors:  Jen A Tan; Kwok M Ho
Journal:  Intensive Care Med       Date:  2010-04-08       Impact factor: 17.440

4.  The effects of increasing plasma concentrations of dexmedetomidine in humans.

Authors:  T J Ebert; J E Hall; J A Barney; T D Uhrich; M D Colinco
Journal:  Anesthesiology       Date:  2000-08       Impact factor: 7.892

5.  Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial.

Authors:  Richard R Riker; Yahya Shehabi; Paula M Bokesch; Daniel Ceraso; Wayne Wisemandle; Firas Koura; Patrick Whitten; Benjamin D Margolis; Daniel W Byrne; E Wesley Ely; Marcelo G Rocha
Journal:  JAMA       Date:  2009-02-02       Impact factor: 56.272

6.  The alpha2-adrenoceptor agonist dexmedetomidine converges on an endogenous sleep-promoting pathway to exert its sedative effects.

Authors:  Laura E Nelson; Jun Lu; Tianzhi Guo; Clifford B Saper; Nicholas P Franks; Mervyn Maze
Journal:  Anesthesiology       Date:  2003-02       Impact factor: 7.892

7.  Use of dexmedetomidine for sedation of children hospitalized in the intensive care unit.

Authors:  Christopher L Carroll; Diane Krieger; Margaret Campbell; Daniel G Fisher; Leonard L Comeau; Aaron R Zucker
Journal:  J Hosp Med       Date:  2008-03       Impact factor: 2.960

8.  Effects of intravenous dexmedetomidine in humans. I. Sedation, ventilation, and metabolic rate.

Authors:  J P Belleville; D S Ward; B C Bloor; M Maze
Journal:  Anesthesiology       Date:  1992-12       Impact factor: 7.892

9.  Prolonged use of dexmedetomidine in the paediatric cardiothoracic intensive care unit.

Authors:  Sharon Bejian; Cassie Valasek; John J Nigro; David C Cleveland; Brigham C Willis
Journal:  Cardiol Young       Date:  2009-01-20       Impact factor: 1.093

10.  Respiratory effects of dexmedetomidine in the surgical patient requiring intensive care.

Authors:  R M Venn; J Hell; R M Grounds
Journal:  Crit Care       Date:  2000-07-31       Impact factor: 9.097

View more
  1 in total

1.  Evaluation of the effects of dexmedetomidine infusion on oxygenation and lung mechanics in morbidly obese patients with restrictive lung disease.

Authors:  Ahmed Hasanin; Kareem Taha; Bassant Abdelhamid; Ayman Abougabal; Mohamed Elsayad; Amira Refaie; Sarah Amin; Shaimaa Wahba; Heba Omar; Mohamed Maher Kamel; Yaser Abdelwahab; Shereen M Amin
Journal:  BMC Anesthesiol       Date:  2018-08-14       Impact factor: 2.217

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.